Insiders Trades

★ Sign in to follow

JS

Jan Skvarka

US·SEC (Form 4)

Trillium Therapeutics Inc.

Cumul. flow

Total declarations

24

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (11 ops.)

€5.6M

Latest filing published 13 May 2021 for Trillium Therapeutics Inc., €150k.

Filing timeline

BuySale

Jan Skvarka

Insider track record

Disclosed buys

0

Disclosed sells

11

Signal history

Jan Skvarka: trading record in brief

Jan Skvarka appears in our data through filings on Trillium Therapeutics Inc. shares, published by SEC (Form 4). Between 25 September 2019 and 12 May 2021, the trades on record add up to 24 filings.

Every open-market trade on record is a sale: 11 sales worth €5.6M. Outside the open market, there are 11 option exercises. In 2021 alone, the filings show no purchases and 5 sales.

The latest filing, published on 13 May 2021, reports an open-market sale of €150k in Trillium Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Jan Skvarka

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Trillium Therapeutics Inc. (US)

Declarations24 total

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 May 2021Trillium Therapeutics Inc.

219,881 CAD13SEDI

23,802 shares@ CA$9.237917.4% of flowCommon SharesTSXSEDI:3743786

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives11 May 2021Trillium Therapeutics Inc.

805,149 CAD17SEDI

87,500 shares@ CA$9.201763.6% of flowCommon SharesTSXSEDI:3743780

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives11 May 2021Trillium Therapeutics Inc.

7,295 CAD11SEDI

19,198 shares@ CA$0.380.6% of flowCommon SharesTSXSEDI:3743782

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives11 May 2021Trillium Therapeutics Inc.

47,250 CAD11SEDI

87,500 shares@ CA$0.543.7% of flowCommon SharesTSXSEDI:3743779

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives11 May 2021Trillium Therapeutics Inc.

176,654 CAD12SEDI

19,198 shares@ CA$9.201714.0% of flowCommon SharesTSXSEDI:3743783

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 May 2021Trillium Therapeutics Inc.

9,045 CAD11SEDI

23,802 shares@ CA$0.380.7% of flowCommon SharesTSXSEDI:3743785

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives25 Sept 2019Trillium Therapeutics Inc.

0SEDI

Common SharesTSXSEDI:3743778

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives14 Jan 2021Trillium Therapeutics Inc.

294,279 CAD13SEDI

19,581 shares@ CA$15.028817.1% of flowCommon SharesTSXSEDI:3663958

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives13 Jan 2021Trillium Therapeutics Inc.

2,926 CAD11SEDI

5,419 shares@ CA$0.540.2% of flowCommon SharesTSXSEDI:3663943

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives14 Jan 2021Trillium Therapeutics Inc.

10,574 CAD11SEDI

19,581 shares@ CA$0.540.6% of flowCommon SharesTSXSEDI:3663955

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives13 Jan 2021Trillium Therapeutics Inc.

81,508 CAD11SEDI

5,419 shares@ CA$15.04114.7% of flowCommon SharesTSXSEDI:3663946

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives16 Dec 2020Trillium Therapeutics Inc.

86,991 CAD0SEDI

161,094 shares@ CA$0.54Common SharesTSXSEDI:3646590

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Dec 2020Trillium Therapeutics Inc.

1M CAD0SEDI

114,007 shares@ CA$11.6244Common SharesTSXSEDI:3646574

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Dec 2020Trillium Therapeutics Inc.

61,564 CAD0SEDI

114,007 shares@ CA$0.54Common SharesTSXSEDI:3646572

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Dec 2020Trillium Therapeutics Inc.

15,538 CAD0SEDI

28,774 shares@ CA$0.54Common SharesTSXSEDI:3646579

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives17 Dec 2020Trillium Therapeutics Inc.

28,500 CAD0SEDI

75,000 shares@ CA$0.38Common SharesTSXSEDI:3646611

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives16 Dec 2020Trillium Therapeutics Inc.

2M CAD0SEDI

161,094 shares@ CA$11.5301Common SharesTSXSEDI:3646591

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives14 Dec 2020Trillium Therapeutics Inc.

2M CAD0SEDI

185,993 shares@ CA$11.804Common SharesTSXSEDI:3646445

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Dec 2020Trillium Therapeutics Inc.

335,289 CAD0SEDI

28,774 shares@ CA$11.6525Common SharesTSXSEDI:3646582

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives14 Dec 2020Trillium Therapeutics Inc.

100,436 CAD0SEDI

185,993 shares@ CA$0.54Common SharesTSXSEDI:3646442

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives17 Dec 2020Trillium Therapeutics Inc.

884,115 CAD0SEDI

75,000 shares@ CA$11.7882Common SharesTSXSEDI:3646613

◇

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives17 Dec 2020Trillium Therapeutics Inc.

18,971 CAD0SEDI

35,132 shares@ CA$0.54Common SharesTSXSEDI:3646608

▼

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives17 Dec 2020Trillium Therapeutics Inc.

414,143 CAD0SEDI

35,132 shares@ CA$11.7882Common SharesTSXSEDI:3646609

●

4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives25 Sept 2019Trillium Therapeutics Inc.

0SEDI

Common SharesTSXSEDI:3646437

24 of 24 declarations